MoneyBall Medicine: Dekel Gelbman and how Machine Learning is changing rare disease diagnosis



To listen to the podcast via iTunes click here

Harry’s guest is Dekel Gelbman, founding CEO of FDNA. The company uses a combination of computer vision, deep learning, and other artificial intelligence techniques to improve and accelerate diagnostics and therapeutics for children with rare diseases.

At MoneyBall Medicine, host Harry Glorikian talks with leaders in the healthcare and life sciences industry about the ongoing data-driven transformation of their industry. Click here for more.